Date published: 2026-5-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

CREM Inhibitors

CREM inhibitorsconstitute a chemical class of compounds designed to selectively and reversibly target the transcription factor known as cAMP response element modulator (CREM). CREM is a crucial regulator of gene expression, responding to cAMP signaling pathways in the cell. These inhibitors are specifically designed to interact with CREM, impeding its transcriptional activity. By doing so, they interfere with the binding of CREM to cAMP-responsive elements within gene promoters, affecting the downstream gene expression patterns influenced by CREM. The interaction between CREM inhibitors and the transcription factor occurs through specific binding sites or regions, disrupting the normal transcriptional regulation mediated by CREM. Researchers employ these inhibitors in biochemical and cellular studies to explore the roles of CREM in gene regulation and its involvement in various cellular processes. The chemical design and optimization of CREM inhibitors rely on a deep understanding of the structural features and functional mechanisms of CREM, aiming to provide valuable insights into its regulatory functions and its relevance in diverse cellular contexts. As the field of gene regulation and transcription factor biology progresses, the development of novel CREM inhibitors continues to be an active area of research for elucidating the complex mechanisms of gene expression control.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

KF 38789

257292-29-8sc-203617
10 mg
$297.00
1
(0)

A synthetic compound that has demonstrated inhibitory effects on CREM activity in experimental studies.

Ro 20-1724

29925-17-5sc-200709
sc-200709A
sc-200709B
100 mg
1 g
5 g
$87.00
$426.00
$1574.00
17
(1)

Although primarily known as a PDE4 inhibitor (phosphodiesterase 4), Ro 20-1724 also exhibits inhibitory effects on CREM.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$138.00
$220.00
$972.00
47
(2)

Originally developed as a PKA (protein kinase A) inhibitor, KT5720 has also been reported to influence CREM signaling.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

A beta-adrenergic receptor agonist that elevates cAMP levels, indirectly affecting CREM signaling.